The bio-based industry faces a number of regulatory and standardisation hurdles for market entry. Based on these barriers, a missing level playing field for bio-based products hampers investments in this industry, which limits the chance of future technological developments and innovations to mature and enter the market at commercial scales. Five main themes have been studied for several product value chains and first conclusions are drawn in a public EU research report.